|
TMEM177 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.398200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.139600E-01 |
| Normal-vs-Stage2 |
1.500200E-01 |
| Normal-vs-Stage3 |
5.212000E-01 |
| Normal-vs-Stage4 |
8.862400E-01 |
| Stage1-vs-Stage2 |
7.433800E-02 |
| Stage1-vs-Stage3 |
4.054200E-01 |
| Stage1-vs-Stage4 |
7.720200E-01 |
| Stage2-vs-Stage3 |
3.189000E-01 |
| Stage2-vs-Stage4 |
8.826300E-02 |
| Stage3-vs-Stage4 |
4.102000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.069600E-01 |
| Normal-vs-AfricanAmerican |
2.903800E-01 |
| Normal-vs-Asian |
4.949400E-01 |
| Caucasian-vs-AfricanAmerican |
3.178400E-01 |
| Caucasian-vs-Asian |
4.932200E-01 |
| AfricanAmerican-vs-Asian |
4.861400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.067800E-01 |
| Normal-vs-Female |
6.783000E-01 |
| Male-vs-Female |
8.285600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.351000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.744000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.787400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.128600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.777700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.932410E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.358400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.817600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.761200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.680400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.212800E-01 |
| Classical-VS-Follicular |
1.684380E-01 |
| Classical-VS-Other |
4.786400E-01 |
| Classical-VS-Normal |
6.742400E-01 |
| Tall-VS-Follicular |
2.944800E-01 |
| Tall-VS-Other |
6.760400E-01 |
| Tall-VS-Normal |
9.881800E-01 |
| Follicular-VS-Other |
3.031600E-01 |
| Follicular-VS-Normal |
2.093800E-01 |
| Other-VS-Normal |
6.410600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.754400E-01 |
| Normal-vs-N1 |
2.615400E-01 |
| N0-vs-N1 |
4.115800E-03 |
|
|
